Evidence map›Paper›PMID 29682326›Full record

ArticleFuture science OA2018

Survival and glycemic control outcomes among patients with coexisting pancreatic cancer and diabetes mellitus.

Nina J Karlin, Shailja B Amin, Heidi E Kosiorek, Matthew R Buras, Patricia M Verona, Curtiss B Cook

Open access · goldAbstract read
In one paragraph

Article in Future science OA, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.0field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Nina J KarlinDivision of Hematology & Medical Oncology, Mayo Clinic Hospital, Phoenix, AZ 85054, USA.
Shailja B AminDivision of Hematology & Medical Oncology, Mayo Clinic Hospital, Phoenix, AZ 85054, USA.
Heidi E KosiorekBiostatistics, Mayo Clinic, Scottsdale, AZ 85259, USA.
Matthew R BurasBiostatistics, Mayo Clinic, Scottsdale, AZ 85259, USA.
Patricia M VeronaDepartment of Information Technology, Mayo Clinic Hospital, Phoenix, AZ 85054, USA.
Curtiss B CookDivision of Endocrinology, Mayo Clinic, Scottsdale, AZ 85259, USA.
Mayo Clinic Hospital · USMayo Clinic in Arizona · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimWe aimed to determine the effect of diabetes mellitus (DM) on survival in pancreatic cancer and effects of pancreatic cancer on glycemic control in DM. MATERIALS &

methodsPatients with pancreatic cancer from 2007 to 2015, with and without DM, were matched 1:1. We compared characteristics between the groups and assessed 2-year survival with Kaplan-Meier analysis.

resultsIn patients with DM, hemoglobin A

conclusionDM did not decrease survival in pancreatic cancer. Pancreatic cancer did not affect glycemic control.

Indexed as

CA 19-9cancerendocrinologyglycemic controloutcomes researchpancreassurvivaltherapy

Identifiers

PMID29682326
PMCPMC5905610
OpenAlexW2788462695

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.